Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Aerpace Industries Ltd.
BSE
Price on BSE
04 Feb,15:01 LIVE
26.10
+0.09
(+0.35%)
© 2026 Rediff.com
Volume :
253,183.00
Prev Close :
26.01
Day's H/L (Rs.) :
26.59 - 25.10
52wk H/L (Rs.) :
36.99 - 16.70
Mkt Cap (Rs. Cr) :
390.20
NSE
Aerpace Industries Ltd. is not listed on NSE
© 2026 Rediff.com
Report Card - Aerpace Industries Ltd.
PE Ratios
-83.66
EPS (Rs.)
-0.31
Sales (Rs. Cr)
0.51
Face Value (Rs.)
1
Net Profit Margin(%)
-298.81
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity
-9.57
News for Iron and Steel
Netflix India Content Strategy with Monika Shergill
Monika Shergill discusses Netflix India's content strategy, diverse programming, and upcoming 2026 slate with new shows and movies.
Feb 04, 2026 14:59
Silver & Gold Rally on Weak Dollar: Safe-Haven Demand
Silver and gold prices rally amid a weak US dollar and global market gains. Investors return after recent corrections, prompting buying.
Feb 04, 2026 14:59
Sebi Overhauls 'Fit and Proper' Framework
Sebi proposes overhaul of 'fit and proper person' framework for market intermediaries. Aims for clarity and fairness.
Feb 04, 2026 14:53
Sun Pharma Sponsors RCB for 3 Years
Sun Pharma partners with Royal Challengers Bengaluru as principal sponsor for 3 years, marking its first cricket sponsorship.
Feb 04, 2026 14:26
NTPC Green Energy Commissions 125 MW Solar Plant
NTPC Green Energy Ltd commissions 125 MW solar capacity in Phalodi, Rajasthan, part of the 500 MW Bhadla Solar PV Project.
Feb 04, 2026 14:25
More News »
Top News
Netflix India Content Strategy with Monika Shergill
Monika Shergill discusses Netflix India's content strategy, diverse programming, and upcoming 2026 slate with new shows and movies.
Feb 04, 2026 14:59
Silver & Gold Rally on Weak Dollar: Safe-Haven Demand
Silver and gold prices rally amid a weak US dollar and global market gains. Investors return after recent corrections, prompting buying.
Feb 04, 2026 14:59
Emcure Pharma Q3 Profit Up 48% YoY at Rs 231 Cr
Emcure Pharma reports Q3 net profit increase of 48% YoY to Rs 231 crore, driven by strong sales growth. Details on revenue and future outlook.
Feb 04, 2026 14:57
Sebi Overhauls 'Fit and Proper' Framework
Sebi proposes overhaul of 'fit and proper person' framework for market intermediaries. Aims for clarity and fairness.
Feb 04, 2026 14:53
Pidilite Expects Export Rebound, Double-Digit Growth
Pidilite Industries anticipates a US export rebound after tariff revisions and expects double-digit volume growth in FY''27.
Feb 04, 2026 14:38
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist